SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 259.60 |
Enterprise Value ($M) | 188.35 |
Book Value ($M) | 210.81 |
Book Value / Share | 4.03 |
Price / Book | 1.23 |
NCAV ($M) | -81.45 |
NCAV / Share | -1.56 |
Price / NCAV | -3.19 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.13 |
Return on Assets (ROA) | -0.11 |
Return on Equity (ROE) | -0.22 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.67 |
Current Ratio | 4.67 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 187.26 |
Assets | 479.51 |
Liabilities | 268.70 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 37.86 |
Operating Income | -105.54 |
Net Income | -57.25 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -85.00 |
Cash from Investing | 80.76 |
Cash from Financing | 0.42 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Beryl Capital Management LLC | 8.10 | ||
13G/A | Kynam Capital Management, LP | 0.00 | -100.00 | |
13G/A | Morgan Stanley | 5.50 | -40.76 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
195,438 | 1,070,323 | 18.26 | |
59,306 | 407,656 | 14.55 | |
116,815 | 793,756 | 14.72 | |
255,068 | 1,120,807 | 22.76 | |
(click for more detail) |
Similar Companies | |
---|---|
TNYA – Tenaya Therapeutics, Inc. | TRML – Tourmaline Bio, Inc. |
TSHA – Taysha Gene Therapies, Inc. | TWST – Twist Bioscience Corporation |
TXMD – TherapeuticsMD, Inc. |
Financial data and stock pages provided by
Fintel.io